Success Metrics

Active Trials
2(50%)

Phase Distribution

Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Other(2)

Detailed Status

Active, not recruiting2
unknown2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

active_not_recruiting250%
unknown250%

Recent Activity

2 active trials
Showing 4 of 4
active_not_recruiting

FSL2 Post Approval Study for Pediatric and Young Adults Patients

NCT04959552
active_not_recruiting

Predicting Dysglycemia in Individuals With Gestational Diabetes Immediately Postpartum Using Continuous Glucose Monitoring

NCT04972955
unknownnot_applicable

Interest of FSL 2 in Recently Diagnosed Type 2 Diabetic Patients

NCT05676593
unknownnot_applicable

Metabolic Adaptation to High-frequent Hypoglycaemia in Type 1 Diabetes

NCT05095259

Clinical Trials (4)

Showing 4 of 4 trials
NCT04959552

FSL2 Post Approval Study for Pediatric and Young Adults Patients

Active Not Recruiting
NCT04972955

Predicting Dysglycemia in Individuals With Gestational Diabetes Immediately Postpartum Using Continuous Glucose Monitoring

Active Not Recruiting
NCT05676593Not Applicable

Interest of FSL 2 in Recently Diagnosed Type 2 Diabetic Patients

Unknown
NCT05095259Not Applicable

Metabolic Adaptation to High-frequent Hypoglycaemia in Type 1 Diabetes

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4